What is the total value of India's pharmaceutical export to United Kingdom?

India exported pharmaceuticals worth $49.4M to United Kingdom across 2,960 verified shipments.

Which companies in United Kingdom import pharmaceuticals from India?

1. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED — $13.2M. 2. NOVARTIS HEALTHCARE PRIVATE LIMITED — $3.3M. 3. RELIANCE LIFE SCIENCES PRIVATE LIMITED — $2.2M. 217 buyers total.

What pharmaceutical products does India export most to United Kingdom?

1. Fluticasone ($16.5M, 33.4%); 2. Fluoxetine ($7.5M, 15.2%); 3. Vaccine ($6.4M, 13.0%); 4. Pazopanib ($3.3M, 6.7%); 5. Serum ($2.8M, 5.7%)

Why does United Kingdom import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $49.4M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply United Kingdom?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to United Kingdom pharmaceutical trade?

$16.7K per consignment across 2,960 shipments.

How many Indian pharmaceutical companies export to United Kingdom?

277 Indian companies. Largest: BIO PRODUCTS LABORATORY LTD. with $18.7M.

How can I find verified Indian pharmaceutical suppliers for United Kingdom?

TransData Nexus covers 277 active exporters with shipment history and trade values at transdatanexus.com.

United Kingdom to India Pharmaceutical Import (2026) — $49.4M, 277 Foreign Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to United Kingdom?

1. BIO PRODUCTS LABORATORY LTD. — $18.7M. 2. GLAXOSMITHKLINE EXPORT LIMITED — $12.2M. 3. Novartis Pharma AG — $3.0M. Total: 277 suppliers.

United Kingdom to India Pharmaceutical Import (2026) — $49.4M, 277 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — United Kingdom to India

#	Formulation	Value	Share
1	Fluticasone	$16.5M	33.4%
2	Fluoxetine	$7.5M	15.2%
3	Vaccine	$6.4M	13.0%
4	Pazopanib	$3.3M	6.7%
5	Serum	$2.8M	5.7%
6	Olaparib	$1.4M	2.9%
7	Sodium	$1.2M	2.4%
8	Gliclazide	$1.0M	2.1%
9	Diltiazem	$760.0K	1.5%
10	Cefuroxime	$600.4K	1.2%
11	Tetracycline	$506.7K	1.0%
12	Tofacitinib	$454.5K	0.9%
13	Ezetimibe	$395.4K	0.8%
14	Quinine	$382.1K	0.8%
15	Atorvastatin	$376.0K	0.8%

India imports 20+ pharmaceutical formulations from United Kingdom with a combined trade value of $49.4M. Key products include Fluticasone ($16.5M), Fluoxetine ($7.5M), Vaccine ($6.4M), Pazopanib ($3.3M), Serum ($2.8M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 2,960 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — United Kingdom to India Trade Routes

1Fluticasone$16.5M

2Fluoxetine$7.5M

3Vaccine$6.4M

4Pazopanib$3.3M

5Serum$2.8M

Top United Kingdom Suppliers to India

1Bio Products Laboratory Ltd.

$18.7M

2Glaxosmithkline Export Limited

$12.2M

3Novartis Pharma Ag

$3.0M

4Bio Products Laboratory Limited

$2.0M

5Bio Products Laboratory Ltd

$1.8M

Trade Statistics

Total Value$49.4M

Shipments2,960

Indian Exporters277

United Kingdom Buyers217

Avg Shipment$17K

Products210

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–United Kingdom Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between the United Kingdom and India has experienced significant growth over the past decade. In 2024, India imported pharmaceutical products valued at approximately $59.15 million from the United Kingdom, marking a substantial increase from previous years. This growth reflects the strengthening of bilateral trade relations and India's increasing reliance on high-quality pharmaceutical imports to meet its domestic healthcare needs.

The United Kingdom's pharmaceutical exports to India encompass a diverse range of products, including vaccines, biologics, and specialized medications. This diversification indicates a robust and expanding trade relationship, with both nations benefiting from the exchange of pharmaceutical goods.

2United Kingdom's Role in India's Pharma Imports

The United Kingdom holds a significant position in India's pharmaceutical import landscape. In 2024, the United Kingdom was among the top suppliers of pharmaceutical products to India, contributing to a substantial portion of India's total pharmaceutical imports. India imports a variety of pharmaceutical products from the United Kingdom, including vaccines, biologics, and specialized medications, which are essential for addressing the country's diverse healthcare requirements.

Recent Developments

United Kingdom Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

For United Kingdom pharmaceutical companies seeking to import products into India, obtaining registration from the Central Drugs Standard Control Organisation (CDSCO) is mandatory. The registration process involves several key steps:

1. Application Submission: Companies must submit an application through the CDSCO's online portal, providing detailed information about the product and manufacturing processes.

2. Documentary Requirements: Essential documents include the Free Sale Certificate, Certificate of Pharmaceutical Product (CPP), and a No Objection Certificate (NOC) from the country of origin.

3. Clinical Trial Data: Depending on the product category, clinical trial data may be required to demonstrate the product's safety and efficacy.

4. Approval Process: The CDSCO reviews the application and, upon satisfactory evaluation, grants the necessary approvals for importation.

The timeline for this process can vary, but it typically ranges from several months to a year, depending on the complexity of the product and the completeness of the application.

2GMP & Manufacturing Standards

India requires that pharmaceutical products imported from the United Kingdom adhere to Good Manufacturing Practice (GMP) standards. Manufacturing sites must be registered with the CDSCO, and products should comply with the World Health Organization's (WHO) prequalification requirements. The CDSCO conducts inspections to ensure that manufacturing facilities meet these standards, focusing on aspects such as quality control, facility hygiene, and production processes.

3Import Documentation

Importing pharmaceutical products into India necessitates the following documentation:

Import License (Form 10): Issued by the CDSCO, this license authorizes the importation of specific pharmaceutical products.

Registration Certificate: Confirms that the product has been approved for sale in India.

No Objection Certificate (NOC): Obtained from the country of origin, this certificate indicates that the exporting country has no objection to the product's export.

Test License: Allows for the testing of imported pharmaceutical products to ensure they meet Indian standards.

Customs Procedures: Compliance with Indian customs regulations is mandatory, including proper labeling, packaging, and payment of applicable duties and taxes.

IMPORT_TRENDS

TransData Nexus Research · United Kingdom regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to United Kingdom identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 2,960 verified shipments from 277 Indian exporters to 217 United Kingdom buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

277 Exporters

217 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

United Kingdom to India Pharmaceutical Import

Top Pharmaceutical Formulations — United Kingdom to India

Top Pharmaceutical Products — United Kingdom to India Trade Routes

Top United Kingdom Suppliers to India

Trade Statistics

Other Import Origins

India–United Kingdom Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2United Kingdom's Role in India's Pharma Imports

Recent Developments

Top Indian Buyers from United Kingdom

Product Routes

Full Dataset Access

United Kingdom Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to United Kingdom

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and United Kingdom

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to United Kingdom Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — United Kingdom for Indian Pharma

1India's Import Dependency

2United Kingdom Companies in India

FAQ — India to United Kingdom Pharmaceutical Trade